drugset / Trial / NCT01843972
Safety of Single Rising Doses and Relative Bioavailability of BI 691751
RandomizedParallel-groupSingle-blindTreatment
Summary
To investigate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics of single rising doses of BI 691751 in healthy male subjects (part I). To investigate the relative bioavailability of BI 691751 given as tablet versus oral solution (part II)
Timeline
- Start
- 2013-04
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 691751 | Unknown | — | Oral |
Indications
No indication recorded.